✦ LIBER ✦

Dipeptidyl peptidase IV inhibitors: A promising new therapeutic approach for the management of type 2 diabetes

✍ Scribed by Carolyn F. Deacon; Jens J. Holst

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dipeptidyl peptidase IV inhibitors as ne

✍ Augustyns, Koen; Van der Veken, Pieter; Senten, Kristel; Haemers, Achiel 📂 Article 📅 2003 🏛 Informa plc 🌐 English ⚖ 189 KB

Sitagliptin: A Dipeptidyl Peptidase IV I

✍ Miller, S. A 📂 Article 📅 2006 🏛 Harvey Whitney Books Company 🌐 English ⚖ 137 KB

Inhibitors of dipeptidyl peptidase IV: a

✍ Deacon, Carolyn F; Ahrén, Bo; Holst, Jens J 📂 Article 📅 2004 🏛 Informa plc 🌐 English ⚖ 209 KB

Incretin Mimetics and Dipeptidyl Peptida

✍ Curtis Triplitt; Alison Wright; Elaine Chiquette 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB

Dipeptidyl peptidase inhibitors as new d

✍ H.-J. Mest; R. Mentlein 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 119 KB

Saxagliptin: a new dipeptidyl peptidase-

✍ Carolyn F. Deacon; Jens J. Holst 📂 Article 📅 2009 🏛 Springer Healthcare Communications 🌐 English ⚖ 223 KB